Armistice Capital LLC Makes New $910,000 Investment in Accuray Incorporated (NASDAQ:ARAY)

Armistice Capital LLC acquired a new position in shares of Accuray Incorporated (NASDAQ:ARAY - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 500,000 shares of the medical equipment provider's stock, valued at approximately $910,000. Armistice Capital LLC owned about 0.50% of Accuray as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Hsbc Holdings PLC grew its holdings in Accuray by 55.1% during the 2nd quarter. Hsbc Holdings PLC now owns 101,683 shares of the medical equipment provider's stock worth $180,000 after acquiring an additional 36,108 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Accuray by 0.3% in the second quarter. Renaissance Technologies LLC now owns 2,812,184 shares of the medical equipment provider's stock valued at $5,118,000 after purchasing an additional 7,500 shares during the period. Perritt Capital Management Inc raised its position in Accuray by 139.3% during the 2nd quarter. Perritt Capital Management Inc now owns 120,000 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 69,864 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Accuray by 6,480.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 35,007 shares of the medical equipment provider's stock worth $64,000 after buying an additional 34,475 shares during the period. Finally, Bank of New York Mellon Corp grew its position in shares of Accuray by 3.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 279,426 shares of the medical equipment provider's stock valued at $509,000 after buying an additional 8,864 shares during the last quarter. Institutional investors and hedge funds own 64.08% of the company's stock.

Accuray Trading Up 2.3 %

Shares of ARAY stock traded up $0.04 on Friday, hitting $1.79. The company had a trading volume of 725,393 shares, compared to its average volume of 675,776. The stock's 50-day moving average is $1.93 and its two-hundred day moving average is $1.97. The company has a debt-to-equity ratio of 3.65, a quick ratio of 0.95 and a current ratio of 1.66. The firm has a market cap of $177.65 million, a P/E ratio of -8.14 and a beta of 1.40. Accuray Incorporated has a twelve month low of $1.40 and a twelve month high of $3.10.

Accuray (NASDAQ:ARAY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.03. Accuray had a negative net margin of 3.48% and a negative return on equity of 33.65%. The firm had revenue of $134.29 million for the quarter, compared to the consensus estimate of $122.80 million. During the same quarter in the previous year, the company earned ($0.03) EPS. On average, equities research analysts anticipate that Accuray Incorporated will post -0.01 earnings per share for the current fiscal year.

Accuray Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.